Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 20 articles: HTML format

Single Articles

January 2025
1. HICKEY MD, Ayieko J, Kabami J, Owaraganise A, et al
   Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study.
   PLoS Med. 2025;22:e1004531.
   PubMed     Abstract available
   
   
   
2. KIM S, Can MH, Agizew TB, Auld AF, et al
   Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
   PLoS Med. 2025;22:e1004502.
   PubMed     Abstract available
   
   
   December 2024
3. GONZALEZ R, Nhampossa T, Figueroa-Romero A, Tchouatieu AM, et al
   Protecting the most vulnerable: The urgent need to include HIV-exposed children in malaria chemoprevention strategies.
   PLoS Med. 2024;21:e1004498.
   PubMed     Abstract available
   
   
   October 2024
4. PIPER JD, Mazhanga C, Mwapaura M, Mapako G, et al
   Growth, physical, and cognitive function in children who are born HIV-free: School-age follow-up of a cluster-randomised trial in rural Zimbabwe.
   PLoS Med. 2024;21:e1004347.
   PubMed     Abstract available
   
   
   
5. LEPINE A, Szawlowski S, Nitcheu E, Cust H, et al
   The effect of protecting women against economic shocks to fight HIV in Cameroon, Africa: The POWER randomised controlled trial.
   PLoS Med. 2024;21:e1004355.
   PubMed     Abstract available
   
   
   
6. HEITNER J, Mwenda V, Umutesi G, Barnabas RV, et al
   Leveraging behavioral economics strategies to close gaps in biomedical HIV prevention.
   PLoS Med. 2024;21:e1004475.
   PubMed     Abstract available
   
   
   September 2024
7. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
   HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
   PLoS Med. 2024;21:e1004452.
   PubMed     Abstract available
   
   
   August 2024
8. ODHIAMBO F, Onyango R, Mulwa E, Aluda M, et al
   Evaluation of person-centered interventions to eliminate perinatal HIV transmission in Kisumu County, Kenya: A repeated cross-sectional study using aggregated registry data.
   PLoS Med. 2024;21:e1004441.
   PubMed     Abstract available
   
   
   
9. GENG EH, Mocumbi A, Mutale W, Davila-Roman V, et al
   Primary care to further improve vertical HIV programming outcomes: From spillover to strategy.
   PLoS Med. 2024;21:e1004434.
   PubMed    
   
   
   July 2024
10. BONNET G, Bimba J, Chavula C, Chifamba HN, et al
    Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    PLoS Med. 2024;21:e1004429.
    PubMed     Abstract available
    
    
    
11. PINTO PFPS, Macinko J, Silva AF, Lua I, et al
    The impact of primary health care on AIDS incidence and mortality: A cohort study of 3.4 million Brazilians.
    PLoS Med. 2024;21:e1004302.
    PubMed     Abstract available
    
    
    June 2024
12. WALSH SR, Gay CL, Karuna ST, Hyrien O, et al
    Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
    PLoS Med. 2024;21:e1004329.
    PubMed     Abstract available
    
    
    May 2024
13. EUVRARD J, Timmerman V, Keene CM, Phelanyane F, et al
    The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.
    PLoS Med. 2024;21:e1004407.
    PubMed     Abstract available
    
    
    
14. VAN DEN ELSHOUT MAM, Wijstma ES, Boyd A, Jongen VW, et al
    Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    PLoS Med. 2024;21:e1004328.
    PubMed     Abstract available
    
    
    
15. MICHALOW J, Walters MK, Edun O, Wybrant M, et al
    Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.
    PLoS Med. 2024;21:e1004385.
    PubMed     Abstract available
    
    
    
16. TELISINGHE L, Floyd S, MacLeod D, Schaap A, et al
    Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2024;21:e1004393.
    PubMed     Abstract available
    
    
    April 2024
17. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    PubMed     Abstract available
    
    
    March 2024
18. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    PubMed     Abstract available
    
    
    
19. MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
    Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
    PLoS Med. 2024;21:e1004360.
    PubMed     Abstract available
    
    
    
20. BRAZIER E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, et al
    Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
    PLoS Med. 2024;21:e1004367.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.